US Patent 7641918 Plasma cryoprecipitate substantially free of plasminogen
Patent 7641918 was granted and assigned to Omrix Biopharmaceuticals on January, 2010 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 7641918 Plasma cryoprecipitate substantially free of plasminogen
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.